IRVIX
Price
$31.28
Change
-$0.74 (-2.31%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

IRVIX vs RMFCX

Header iconIRVIX vs RMFCX Comparison
Open Charts IRVIX vs RMFCXBanner chart's image
Voya Russell Large Cap Value Idx Port I
Price$31.28
Change-$0.74 (-2.31%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
IRVIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IRVIX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRVIX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. IRVIX (214M). IRVIX pays higher dividends than RMFCX: IRVIX (1.84) vs RMFCX (1.69). IRVIX was incepted earlier than RMFCX: IRVIX (16 years) vs RMFCX (23 years). IRVIX is a more actively managed with annual turnover of: 33.00 vs. RMFCX (25.00). IRVIX has a lower initial minimum investment than RMFCX: IRVIX (0) vs RMFCX (250). IRVIX annual gain was more profitable for investors over the last year : 16.06 vs. RMFCX (9.39). IRVIX return over 5 years is better than : 45.22 vs. RMFCX (36.51).
IRVIXRMFCXIRVIX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD14.8368.896167%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets214M98.7B0%
Annual Yield % from dividends1.841.69109%
Returns for 1 year16.069.39171%
Returns for 3 years22.7111.57196%
Returns for 5 years45.2236.51124%
Returns for 10 years92.5558.17159%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc